
By BY SHERYL GAY STOLBERG, CHRIS HAMBY AND REBECCA R. RUIZ from NYT Emergent BioSolutions faces scrutiny in Congress for ruining Covid-19 vaccines and securing lucrative federal contracts. Executives will appear before some lawmakers who benefited from the company’s spending.U.S. https://ift.tt/2S3ZwOf
via
0 comments:
Post a Comment